Basics Aytu BioScience, Inc. Aytu BioScience Inc is engaged in acquiring, developing and commercializing products in the field of urology. It focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. IPO Date: May 23, 2017 Sector: Healthcare Industry: Pharma Market Cap: $12.22M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 3.91% Avg Daily Range (30 D): $0.06 | 3.87% Avg Daily Range (90 D): $0.05 | 3.12% Institutional Daily Volume Avg Daily Volume: 1.58M Avg Daily Volume (30 D): 1.93M Avg Daily Volume (90 D): .66M Trade Size Avg Trade Size (Sh.): 480 Avg Trade Size (Sh.) (30 D): 212 Avg Trade Size (Sh.) (90 D): 214 Institutional Trades Total Inst.Trades: 67 Avg Inst. Trade: $1.58M Avg Inst. Trade (30 D): $.76M Avg Inst. Trade (90 D): $.76M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.59M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 20.99K         News Jul 17, 2024 @ 11:03 AM Presenting on the Emerging Growth Conference 73 Da... Source: N/A Nov 15, 2023 @ 7:04 PM Why Shapeways Holdings Shares Are Trading Lower By... Source: Lisa Levin Sep 28, 2023 @ 5:04 PM Why CarMax Shares Are Trading Lower By Around 10%?... Source: Lisa Levin Sep 28, 2023 @ 3:55 PM Best Penny Stocks? 4 Hot Stocks With News This Wee... Source: J. Samuel Aug 9, 2023 @ 3:00 PM Benzinga's Top Ratings Upgrades, Downgrades For Au... Source: Benzinga Insights Financials   TTM Q2 2025 Q1 2025 Basic EPS $.65 $.13 $.24 Diluted EPS $.21 $-.26 $-.15 Revenue $ 18.45M $ 16.22M $ 16.57M Gross Profit $ 12.81M $ 10.79M $ 11.99M Net Income / Loss $ 3.99M $ .79M $ 1.47M Operating Income / Loss $ 2.42M $ -1.7M $ -.93M Cost of Revenue $ 5.65M $ 5.44M $ 4.59M Net Cash Flow $ -2.23M $ $ PE Ratio 8.52     Splits Jan 06, 2023:   1:20 Dec 09, 2020:   1:10 Aug 13, 2018:   1:20 Aug 29, 2017:   1:20 Jul 01, 2016:   1:12 Jun 10, 2015:   11:134